# OnCo record nct06509126 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06509126/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06509126", "NCT06509126" ;
  schema:name "Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer"@en ;
  schema:alternateName "IMPROVE-2"@en ;
  schema:description "A phase 3 trial of panitumumab, fOLFIRI (5-FU, leucovorin, irinotecan) and fluorouracil (5-FU) in colorectal cancer, run by National Cancer Institute, Naples, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06509126/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06509126> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/fluorouracil/> .